Increased susceptibility to kainate‐induced seizures in a mouse model of tuberous sclerosis complex: Importance of sex and circadian cycle

Documenti analoghi

• Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox–Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
  di: Robert T. Wechsler, et al.
  Pubblicazione: (2024)
• Long‐term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3‐year results from the cannabidiol expanded access program
  di: Arie Weinstock, et al.
  Pubblicazione: (2024)
• An iEEG investigation on sex‐specific differences in seizure duration
  di: Paula Albert I Gracenea, et al.
  Pubblicazione: (2026)
• Calpastatin, a calpain specific inhibitor, reduce seizures in a mouse model of temporal lobe epilepsy
  di: Philip M. Lam, et al.
  Pubblicazione: (2025)
• The small molecule simufilam dose‐dependently attenuates the worsening of seizures in a mouse model of tuberous sclerosis complex
  di: Branden Stansley, et al.
  Pubblicazione: (2026)